CS logo
small CS logo
PT Equilab International

Jakarta, Indonesia
Corporate office
JL. RS. Fatmawati Persil 33, RT.2/RW.5, West Cilandak, Cilandak, South Jakarta City, Jakarta 12430

About PT Equilab International


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at PT Equilab International


During the past decade, PT Equilab International conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "PT Equilab International" #1 collaborator was "PT. Equilab International" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at PT Equilab International


According to Clinical.Site data, the most researched conditions in "PT Equilab International" are "Healthy" (8 trials), "Glimepiride BE Study in Healthy Volunteers Under Fasting Condition" (1 trials) and "Metformin XR BE Study in Healthy Volunteers With Single and Multiple Dose" (1 trials). Many other conditions were trialed in "PT Equilab International" in a lesser frequency.

Clinical Trials Intervention Types at PT Equilab International


Most popular intervention types in "PT Equilab International" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "500 mg metformin hydrochloride extended release caplet (test drug)" (1 trials), "500 mg metformin hydrochloride prolonged release tablet (reference drug)" (1 trials), "Arcoxia® 120 mg Film-coated tablet (Frosst Iberica S.A., Spain for Merck Sharp & Dohme (Australia) Pty Limited, Australia, registered by PT. Schering-Plough Indonesia Tbk)" (1 trials), "DLBS1033" (1 trials) and "Etoricoxib 120Mg Film-coated Tablet" (1 trials). Other intervention names were less common.

Clinical Trials Genders at PT Equilab International


The vast majority of trials in "PT Equilab International" are 10 trials for "All" genders.

Clinical Trials Status at PT Equilab International


Currently, there are NaN active trials in "PT Equilab International". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in PT Equilab International, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in PT Equilab International, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".